Phase 2 Multiple Sclerosis Trial, Not Yet Recruiting NCT07631143 Sponsor: University of Saskatchewan Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Phase 2 Multiple Sclerosis Trial, Not Yet Recruiting

NCT07631143
Not Yet Recruiting Phase 2

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Group 1: People who have been diagnosed with MS and have a higher level of physical disability (based on a standard MS disability scale score between 6.5 and 9), and who have not had a relapse in at least 90 days, and who are over 18 years old.
  • Group 2: People who have been diagnosed with relapsing remitting MS, have experienced a significant relapse that started within the past 4 weeks causing a measurable increase in disability, and who are over 18 years old.
  • Group 3: People who have been diagnosed with a progressive form of MS (either Primary or Secondary Progressive) that has been stable — meaning no relapses and no new or worsening brain scan changes in the past year — with a lower disability scale score (6.5 or below), and who are over 18 years old.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are pregnant.
  • People who have been diagnosed with certain breathing or lung conditions, including obstructive sleep apnea, chronic obstructive pulmonary disease (COPD), uncontrolled asthma, low oxygen lung disease, or a respiratory infection in the past 3 months.
  • People who have a history of reduced blood supply to the heart (such as angina or a heart attack).
  • People who have an irregular heart rhythm.
  • People with severely high blood pressure (above 160/100).
  • People who have a seizure disorder (such as epilepsy).
  • People whose health is currently unstable for another medical reason (confirm with trial site).
  • People who are not able to give informed consent to participate.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026

Contact this trial

Phone: 306-655-7742

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 2
Sponsor
University of Saskatchewan
Registry
ClinicalTrials.gov
Start date
1 July 2026
Est. completion
1 August 2028

Primary endpoints

SpO2 < 78%, Heart rate < 50 beats per minute (bpm) or > 160 bpm

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov